A press release from Cerapedics informs that their i-Factor product line has a new entry that has just been approved in Europe for distribution.
From the press release:
i-FACTOR bone graft is the only biologic bone graft that combines a unique anorganic bone mineral (ABM) and small peptide (P-15™) to act as an attachment factor for specific integrins on osteogenic cells. This novel mechanism of action enhances the body’s natural bone healing process resulting in safe, predictable bone formation at a lower cost than growth factors. ABM/P-15 has been in human clinical use for more than thirteen years in an estimated 500,000 patients worldwide.
Video and links below the fold:
Press release: Cerapedics, Inc. receives CE mark for i-FACTOR™ Flex bone graft…
Product site: i-Factor Flex…